Checked 2026-11-10. Independent clinical review has not been completed. WADAFUK is independent of WADA and does not provide medical advice or an individual anti-doping determination.
Prohibited at all times
2026 S3: prohibited at all times; Specified. No dose-based inhaled exception is stated for this substance. [1]
S3; printed p. 9 and relevant S5 note, p. 12 · 2026 rules apply from 1 January 2026. Any 2027 material below concerns future rules from 1 January 2027; it is not current clearance.
Supplement exposure and safety
A 2022 FDA warning letter documented a product label declaring higenamine and identified it as a constituent of several botanicals. FDA stated that the available evidence did not provide reasonable assurance of safety for dietary-ingredient use. Plant origin does not establish safety or anti-doping permission. [2]
- Historical enforcement assessment, not a current batch assay or clinical event-rate estimate. Different botanical preparations need not contain comparable amounts.
What remains uncertain
- The cited 24-product analytical paper could not be retrieved beyond search excerpts. Its numerical assay results and the draft’s food-exposure studies are not published in this version.
Check the sources.
These are concise editorial paraphrases of selected sources, not a systematic review or a reproduction of source tables. Access depth is shown for each reference; an abstract-only check cannot resolve details found only in a full paper.
- WADA 2026 Prohibited List ↗Accessed 2026-11-10 · Relevant official full-text sections opened
Printed pp. 3, 9–12: introduction, S3, S4 and S5 as applicable
- FDA Ironmag Labs warning letter ↗Accessed 2026-11-10 · Relevant document text opened
Relevant cited sections
Check the current official WADA List and the relevant anti-doping authority for your sport, product, route and circumstances. Do not stop or change necessary treatment based on this page. Ask a qualified clinician about health decisions. Missing evidence does not establish safety.